Delivery Order SPE2DB20D3103-SPE2DB25FL4B9
Award Date
10/17/24
Potential Completion Date
10/18/24
Potential Value
$39K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers to the Defense Logistics Agency (DLA). The $1,066.20 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 20, 2025 and was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This contract award is for the delivery of fluticasone propionate HFA 44 mcg inhalers, valued at $1,151.12, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract is a firm fixed-price delivery order with a completion date of January 9, 2024. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
The federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers to the Defense Logistics Agency (DLA). The $9,255.34 firm fixed price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded solely to Amerisourcebergen Drug...
This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a ceiling value of $1,041.72 and a period of performance through November 3, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalation aerosol to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,574.26. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating it was an open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of fluticasone propionate HFA 44 mcg 10.6 gm to the Defense Logistics Agency (DLA). The $2,846.20 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through November 4, 2024 and was not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,738.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone propionate HFA 110 mcg inhalers, with a completion date of April 30, 2025. The contract is a delivery order, with a firm fixed-price pricing type. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of fluticasone propionate HFA 220 mcg 12 gm inhalers to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $3,369.53. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12g inhalers. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $10,991.70 and a completion date of May 28, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers to the Defense Logistics Agency (DLA). The $2,211.56 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 12, 2024 with a completion date of November 13, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...